Showing 1 - 2 results of 2 for search 'Ou SH', query time: 0.01s Refine Results
  1. 1
    Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond

    Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond by Ou SH

    Published 2011
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Dacomitinib in lung cancer: a “lost generation” EGFR tyrosine-kinase inhibitor from a bygone era?

    Dacomitinib in lung cancer: a “lost generation” EGFR tyrosine-kinase inhibitor from a bygone era? by Ou SH, Soo RA

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: